1 active not recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
Follow Casdozokitug: new trials by email Literature Review of Casdozokitug trials Research Report on Casdozokitug
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma Casdozokitug, Toripalimab, Bevacizumab - Hepatocellular Carcinoma | Phase 2 | Active not recruiting | Coherus Oncology, Inc. | 72 | 2024-12-20 | 2026-07-15 |
| Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma Casdozokitug, Atezolizumab, Bevacizumab - Hepatocellular Carcinoma | Phase 2 | Terminated | Coherus Oncology, Inc. | 30 | 2022-04-12 | 2026-10-01 |
Carcinoma, Hepatocellular (2) · Liver Neoplasms (2) · Neoplasms (1)
Australia (2) · Taiwan (2) · United States (2) · Canada (1) · Hong Kong (1) · Singapore (1) · South Korea (1)